Results 261 to 270 of about 660,646 (336)

The “Hand-as-Foot” teaching method for acute ST-segment elevation myocardial infarction

Lichao Qin, Yuzhen Ning
openalex   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

A Diagnostic Paradigm Shift in Acute Myocardial Infarction: Rationale and Design of the DIFOCCULT-3 Trial. [PDF]

JACC Adv
Aslanger EK, Aggül B, Yıldırımtürk Ö, Karabay CY, Meyers HP, Smith SW, Değertekin M, DIFOCCULT-3 Study Investigators, Steering Committee, Expert ECG Board, Investigators, Data Monitoring Board, Safety Monitoring and Outcome Adjudication Board.   +12 more
europepmc   +1 more source

Primary percutaneous coronary intervention in elderly patients with ST-elevation acute myocardial infarction

, 2006
Weifeng Shen
openalex   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Implications of a new clinical classification of acute myocardial infarction. [PDF]

Eur Heart J Acute Cardiovasc Care
Thurston AJF, Boeddinghaus J, Chapman AR, Lindahl B, Mills NL.   +4 more
europepmc   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Occupational status and outcomes in acute myocardial infarction: a prospective cohort study. [PDF]

BMC Public Health
Zhu Y, Wang J, Cai Q, Qiao Y, Yang J, Xu H, Su S, Gao X, Li W, Yang Y, China Acute Myocardial Infarction Registry Investigators.   +10 more
europepmc   +1 more source

A Successful Coronary Artery Bypass Operation with Intermittent Factor VIII Administration in a Hemophilia A Patient Who Was Admitted Due to Acute Myocardial Infarction: A Rare and Difficult Case

, 2019
Ulaş Serkan Topaloğlu, Rıfat Özmen, Recep Civan Yüksel, Murat Çetin, Gülşah Akyol   +4 more
openalex   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source